These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 27588448)

  • 21. MME mutation in dominant spinocerebellar ataxia with neuropathy (SCA43).
    Depondt C; Donatello S; Rai M; Wang FC; Manto M; Simonis N; Pandolfo M
    Neurol Genet; 2016 Oct; 2(5):e94. PubMed ID: 27583304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exome sequencing identifies a DYNC1H1 mutation in a large pedigree with dominant axonal Charcot-Marie-Tooth disease.
    Weedon MN; Hastings R; Caswell R; Xie W; Paszkiewicz K; Antoniadi T; Williams M; King C; Greenhalgh L; Newbury-Ecob R; Ellard S
    Am J Hum Genet; 2011 Aug; 89(2):308-12. PubMed ID: 21820100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The novel neurofilament light (NEFL) mutation Glu397Lys is associated with a clinically and morphologically heterogeneous type of Charcot-Marie-Tooth neuropathy.
    Züchner S; Vorgerd M; Sindern E; Schröder JM
    Neuromuscul Disord; 2004 Feb; 14(2):147-57. PubMed ID: 14733962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Similar clinical, pathological, and genetic features in Chinese patients with autosomal recessive and dominant Charcot-Marie-Tooth disease type 2K.
    Fu J; Dai S; Lu Y; Wu R; Wang Z; Yuan Y; Lv H
    Neuromuscul Disord; 2017 Aug; 27(8):760-765. PubMed ID: 28495047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SBF1 mutations associated with autosomal recessive axonal neuropathy with cranial nerve involvement.
    Manole A; Horga A; Gamez J; Raguer N; Salvado M; San Millán B; Navarro C; Pittmann A; Reilly MM; Houlden H
    Neurogenetics; 2017 Jan; 18(1):63-67. PubMed ID: 28005197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MORC2 mutations cause axonal Charcot-Marie-Tooth disease with pyramidal signs.
    Albulym OM; Kennerson ML; Harms MB; Drew AP; Siddell AH; Auer-Grumbach M; Pestronk A; Connolly A; Baloh RH; Zuchner S; Reddel SW; Nicholson GA
    Ann Neurol; 2016 Mar; 79(3):419-27. PubMed ID: 26659848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitofusin 2 gene mutation (R94Q) causing severe early-onset axonal polyneuropathy (CMT2A).
    Neusch C; Senderek J; Eggermann T; Elolff E; Bähr M; Schneider-Gold C
    Eur J Neurol; 2007 May; 14(5):575-7. PubMed ID: 17437620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The phenotypic manifestations of autosomal recessive axonal Charcot-Marie-Tooth due to a mutation in Lamin A/C gene.
    Chaouch M; Allal Y; De Sandre-Giovannoli A; Vallat JM; Amer-el-Khedoud A; Kassouri N; Chaouch A; Sindou P; Hammadouche T; Tazir M; Lévy N; Grid D
    Neuromuscul Disord; 2003 Jan; 13(1):60-7. PubMed ID: 12467734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Molecular genetics of inherited neuropathies].
    Takashima H
    Rinsho Shinkeigaku; 2006 Jan; 46(1):1-18. PubMed ID: 16541790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Charcot-Marie-Tooth disease with giant axons: a clinicopathological and genetic entity.
    Lus G; Nelis E; Jordanova A; Löfgren A; Cavallaro T; Ammendola A; Melone MA; Rizzuto N; Timmerman V; Cotrufo R; De Jonghe P
    Neurology; 2003 Oct; 61(7):988-90. PubMed ID: 14557576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HADHB mutations cause infantile-onset axonal Charcot-Marie-Tooth disease: A report of two cases.
    Lu Y; Wu R; Meng L; Lv H; Liu J; Zuo Y; Zhang W; Yuan Y; Wang Z
    Clin Neuropathol; 2018; 37(5):232-238. PubMed ID: 29956646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SCO2 mutations cause early-onset axonal Charcot-Marie-Tooth disease associated with cellular copper deficiency.
    Rebelo AP; Saade D; Pereira CV; Farooq A; Huff TC; Abreu L; Moraes CT; Mnatsakanova D; Mathews K; Yang H; Schon EA; Zuchner S; Shy ME
    Brain; 2018 Mar; 141(3):662-672. PubMed ID: 29351582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel autosomal dominant GDAP1 mutation in an Italian CMT2 family.
    Manganelli F; Pisciotta C; Nolano M; Capponi S; Geroldi A; Topa A; Bellone E; Suls A; Mandich P; Santoro L
    J Peripher Nerv Syst; 2012 Sep; 17(3):351-5. PubMed ID: 22971097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GDAP1 mutations in Italian axonal Charcot-Marie-Tooth patients: Phenotypic features and clinical course.
    Pezzini I; Geroldi A; Capponi S; Gulli R; Schenone A; Grandis M; Doria-Lamba L; La Piana C; Cremonte M; Pisciotta C; Nolano M; Manganelli F; Santoro L; Mandich P; Bellone E
    Neuromuscul Disord; 2016 Jan; 26(1):26-32. PubMed ID: 26525999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mild early onset axonal Charcot-Marie-Tooth disease not linked to other axonal Charcot-Marie-Tooth loci.
    Kochanski A; Kennerson M; Kawulak M; Ryniewicz B; Rowinska-Marcinska K; Walizada G; Nowakowski A; Hausmanowa-Petrusewicz I; Nicholson GA
    Neurology; 2005 Feb; 64(3):533-5. PubMed ID: 15699389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutations in alpha-B-crystallin cause autosomal dominant axonal Charcot-Marie-Tooth disease with congenital cataracts.
    Cortese A; Currò R; Ronco R; Blake J; Rossor AM; Bugiardini E; Laurà M; Warner T; Yousry T; Poh R; Polke J; Rebelo A; Dohrn MF; Saporta M; Houlden H; Zuchner S; Reilly MM
    Eur J Neurol; 2024 Jan; 31(1):e16063. PubMed ID: 37772343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutations in the neurofilament light chain gene (NEFL) cause early onset severe Charcot-Marie-Tooth disease.
    Jordanova A; De Jonghe P; Boerkoel CF; Takashima H; De Vriendt E; Ceuterick C; Martin JJ; Butler IJ; Mancias P; Papasozomenos SCh; Terespolsky D; Potocki L; Brown CW; Shy M; Rita DA; Tournev I; Kremensky I; Lupski JR; Timmerman V
    Brain; 2003 Mar; 126(Pt 3):590-7. PubMed ID: 12566280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hereditary spastic paraplegia is a novel phenotype for germline de novo ATP1A1 mutation.
    Stregapede F; Travaglini L; Rebelo AP; Cintra VP; Bellacchio E; Bosco L; Alfieri P; Pro S; Zuchner S; Bertini E; Nicita F
    Clin Genet; 2020 Mar; 97(3):521-526. PubMed ID: 31705535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early onset severe and late-onset mild Charcot-Marie-Tooth disease with mitofusin 2 (MFN2) mutations.
    Chung KW; Kim SB; Park KD; Choi KG; Lee JH; Eun HW; Suh JS; Hwang JH; Kim WK; Seo BC; Kim SH; Son IH; Kim SM; Sunwoo IN; Choi BO
    Brain; 2006 Aug; 129(Pt 8):2103-18. PubMed ID: 16835246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel TFG mutation causes Charcot-Marie-Tooth disease type 2 and impairs TFG function.
    Tsai PC; Huang YH; Guo YC; Wu HT; Lin KP; Tsai YS; Liao YC; Liu YT; Liu TT; Kao LS; Yet SF; Fann MJ; Soong BW; Lee YC
    Neurology; 2014 Sep; 83(10):903-12. PubMed ID: 25098539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.